State department of health deputy commissioner Keith Reed said Sunday that the state should expect to get 31,500 doses of the Johnson & Johnson COVID-19 vaccine. The doses could arrive in Oklahoma as early this week.
The Food and Drug Administration issued the emergency use authorization notice for the single-dose vaccine on Saturday. It is the third to gain emergency use status alongside the Pfizer and Moderna COVID-19 vaccines.
The J&J vaccine has proven to be around 65% effective at preventing serious illness due to the virus.
Lynn Institute CEO Carlos Blanco said the institute is working to get that percentage higher by testing out a two-dose vaccine similar to others on the market.
“Now, they are testing the double shot version of that vaccine to see if they can get them up to the higher level like Pfizer and Modera with 94% and 95%,” Blanco said.
The Lynn Institute has played a vital role in pushing us to this point in the vaccine rollout. It has held multiple clinical trials which has allowed companies access to safety data on the vaccine they need in order to file for and gain emergency use authorization.
“We just finished the trial for the Novavax vaccine and expect them to apply for EUA soon, as well,” Blanco said.
Blanco said the more vaccines available on the market, the better chance we have at putting a halt to the pandemic.